You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 132 No. 2, February 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  REVIEW
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (138)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Adjuvant Therapy of Pemphigus

An Update

Jean-Claude Bystryn, MD; Natasha M. Steinman, MD

Arch Dermatol. 1996;132(2):203-212.


Abstract



Systemic corticosteroids remain the mainstay of therapy for pemphigus. Their use has transformed what was almost invariably a fatal illness into one whose mortality is now below 10%. Unfortunately, the high doses and prolonged administration of corticosteroids that are often needed to control the disease result in numerous side effects, many of which are serious. Most patients who die of pemphigus at present die of complications of therapy. This has led to a continued search for alternative treatments that might reduce the need for steroids. Those treatments now in use are usually given in combination with steroids and, for that reason, are referred to as adjuvant therapies. This article summarizes progress in the adjuvant therapy of pemphigus since the last review of this subject 10 years ago.

(Arch Dermatol. 1996;132:203-212)



Author Affiliations



From The Ronald O. Perelman Department of Dermatology, New York University Medical Center, New York, NY.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus.
Beissert et al.
Arch Dermatol 2006;142:1447-1454.
ABSTRACT | FULL TEXT  

Prevention of Osteoporosis Associated With Chronic Glucocorticoid Therapy
Heffernan et al.
JAMA 2006;295:1300-1303.
FULL TEXT  

Treatment of Refractory Pemphigus Vulgaris With Rituximab (Anti-CD20 Monoclonal Antibody)
Dupuy et al.
Arch Dermatol 2004;140:91-96.
ABSTRACT | FULL TEXT  

Pathology Quiz Case 2--Diagnosis
Arch Otolaryngol Head Neck Surg 2003;129:256-257.
FULL TEXT  

PEMPHIGUS VULGARIS: UPDATE ON ETIOPATHOGENESIS, ORAL MANIFESTATIONS, AND MANAGEMENT
Scully and Challacombe
CROBM 2002;13:397-408.
ABSTRACT | FULL TEXT  

Corticosteroid-Sparing Effect of Intravenous Immunoglobulin Therapy in Patients With Pemphigus Vulgaris
Sami et al.
Arch Dermatol 2002;138:1158-1162.
ABSTRACT | FULL TEXT  

Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit
Wozniacka et al.
Lupus 2002;11:71-81.
ABSTRACT  

Penile Pemphigus
Sami and Ahmed
Arch Dermatol 2001;137:756-758.
ABSTRACT | FULL TEXT  

Ineffectiveness of Cyclosporine as an Adjuvant to Corticosteroids in the Treatment of Pemphigus
Ioannides et al.
Arch Dermatol 2000;136:868-872.
ABSTRACT | FULL TEXT  

Immune Modulation in Pemphigus Vulgaris: Role of CD28 and IL-10
Toto et al.
J. Immunol. 2000;164:522-529.
ABSTRACT | FULL TEXT  

Methotrexate as an Adjuvant Treatment for Pemphigus Vulgaris
Smith and Bystryn
Arch Dermatol 1999;135:1275-1276.
FULL TEXT  

Pemphigus--Diseases of Antidesmosomal Autoimmunity
Udey and Stanley
JAMA 1999;282:572-576.
FULL TEXT  

Is Mycophenolic Acid Effective for the Treatment of Pemphigus?
Bystryn et al.
Arch Dermatol 1999;135:854-855.
FULL TEXT  

Pulse Intravenous Cyclophosphamide Therapy in Pemphigus
Fleischli et al.
Arch Dermatol 1999;135:57-61.
ABSTRACT | FULL TEXT  

Therapy of Pemphigus Vulgaris
Stanley
Arch Dermatol 1999;135:76-78.
FULL TEXT  

Treatment of Pemphigus With Gold
Pandya and Dyke
Arch Dermatol 1998;134:1104-1107.
ABSTRACT | FULL TEXT  

Pulse Glucocorticoid Therapy: The 'Big Shot' Revisited
Roujeau
Arch Dermatol 1996;132:1499-1502.
ABSTRACT  

Curative Treatment for Pemphigus
Pasricha and Khaitan
Arch Dermatol 1996;132:1518-1519.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.